| - | | hepatoprotective therapy by slit2 | 김영화, 박태준, 최재호 |
| - | | biomarker composition for diagnosis of lymph node metastasis | 김장희, 박순상, 박태준, 이영경 |
| - | | biomarker composition for detecting senescent tumor cells | 김장희, 박순상, 박태준, 이영경 |
| - | | cell senescence measurement method with improved accuracy and cell senescence/reverse-senescence drug screening method using the same | 박태준, 이진구 |
| - | | method for detecting senescent tumor cells | 김장희, 박순상, 박태준 |
| - | | composition for inhibiting skin aging | 강희영, 김진철, 박영준, 박태준 |
| - | | biomarker composition for diagnosing colorectal cancer senescent tumor cells comprising p15 protein or the gene encoding it | 김장희, 박순상, 박태준, 이영경 |
| - | | the composition for killing a therapy-induced senescence(tis) cells and uses thereof | 박태준, 최용원 |
| - | | Compositions and Combination Therapies for Preventing or Treating Cancer comprising Chemokine Inhibitor, Colony Stimulating Factor Inhibitor, and Immune Checkpoint Inhibitor | 김장희, 박태준, 최용원 |
| - | | Composition containing B-cell lymphoma 2 inhibitor for anti-aging and whitening | 강희영, 박태준 |
| 2026 | | composition for inducing reverse aging containing slit2 and method for inducing reverse aging | 김영화, 김장희, 박태준, 이영경 |
| 2022 | | Compositions and Combination Therapies for Preventing or Treating Cancer comprising Chemokine Inhibitor, Colony Stimulating Factor Inhibitor, and Immune Checkpoint Inhibitor | 김장희, 박태준, 최용원 |
| 2020 | | Screening method for skin whitening agents using SDF1 promoter region | 강희영, 박태준 |
| 2018 | | Composition for regulating cutaneous pigmentation or skin whitening comprising SDF1 | 강희영, 김미선, 박태준 |
| 2018 | | Composition for skin whitening comprising clusterin | 강희영, 김미선, 박태준 |
| 2017 | | Composition for regulating cutaneous pigmentation derived from endothelial cells or secretory factors from endothelial cells and method for screening skin whitening agents | 강희영, 김미선, 박지윤, 박태준 |
| 2016 | | Composition for treating pigmentary disorder or whitening skin through pleiotrophin modulation | 강희영, 박태준 |
